Effects of Extracorporeal Treatment in Patients With Acute Poisoning

Effects of Extracorporeal Treatment in Patients With Acute Poisoning in Jiangsu Province, China: A Multi-center Target Trial Emulation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06798129

Enrollment

5269

Registered

2025-01-29

Start date

2015-01-01

Completion date

2026-12-31

Last updated

2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Treatment, Poisoning

Brief summary

This study aims to estimate the effect of extracorporeal treatments (ECTRs) on 28-day survival in patients with acute poisoning. The treatment strategy was receipt of ECTR (hemoperfusion, hemodialysis, continuous kidney replacement therapy, and/or or plasma exchange) versus a non-ECTR strategy.

Interventions

PROCEDUREExtracorporeal Treatment

Extracorporeal treatments include hemoperfusion, hemodialysis, continuous kidney replacement therapy, and plasma exchange.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

* 12 years of age and older * History of acute poisoning

Exclusion criteria

* missing records in survival outcome

Design outcomes

Primary

Measure	Time frame
Survival outcome	28 days within the index date of presentation at emergency department

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026